XII.JSE Numeral Limited

Healthcare Drug Manufacturers - Specialty & Generic Johannesburg Exchange
30.00 ZAC
Close of Oct 29, 2026
0.0100 35.00
Market cap
ZAC 373M
P/E
-
P/B
2,973.36x
ROE
2.5%
Dividend yield
-
Fundamental score
0.5/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.

Is XII.JSE undervalued?

Graham number

The Graham number of Numeral Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Numeral Limited fundamental analysis

3 of 22 checks passed

ROE 0/2

Low return on equity (2.5%), below 10%.

ROA 0/1

Return on assets (0.3%) is below the industry median (3.7%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-99.3%) is below the industry median (24.7%).

Revenue Growth 0/2

Revenue did not grow over the past 3 years or is not reported.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 0/2

High debt to equity (628.6%), above 100%.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is 1.6x against interest expense, below 5x.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (29.7x) is above the industry median (2.6x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Numeral Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Numeral Limited

Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. In addition, it offers stem-cell harvesting, st…

Full company profile